News
Laurent Pharmaceuticals to receive investment from Cystic Fibrosis Canada
17 March 2016
Laurent Pharmaceuticals Inc. announced today the closing of a financing round led by Cystic Fibrosis Canada. Existing investors Aligo Innovation LP...
Read MoreLaurent Pharmaceuticals featured in BioCentury Magazine
15 September 2015
Laurent Pharmaceuticals Inc. announced today that the LAU-7b program addressing aberrant inflammation is featured in the September 14th issue of BioCentury, one of...
Read MoreEVENTS
Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA
Laurent Pharma to participate to BIO International Convention, June 3-6 2024, San Diego, CA, USA
Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA
Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA
Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022